AGMB Stock Latest News
The FlyAgomab Therapeutics NV trading resumes3w agoAGMB
Company AnnouncementsAgomab Doses First Patient in Global Phase 2b NOV-ERA Trial for Fibrostenosing Crohn’s Disease1M ago6KAGMB
Company AnnouncementsAgomab Moves Inhaled IPF Drug AGMB-447 Into Phase 2 After Positive Phase 1 Results2M ago6KAGMBCompany AnnouncementsAgomab Shareholders Approve New Board Members and Pre-IPO Warrant Adjustment2M ago6KAGMB
Company AnnouncementsAgomab Proposes New Board Members and Plans Warrant Adjustment Ahead of September 11 Meetings3M ago6KAGMB
Company AnnouncementsAgomab Posts Half-Year 2026 Results, Advances Fibro-Inflammation Pipeline After Nasdaq IPO3M ago6KAGMB
- Company AnnouncementsAgomab Details NOV-ERA Phase 2b Trial Design for Ontunisertib in Fibrostenosing Crohn’s Disease5M ago6KAGMB
The FlyAgomab announces NOV-ERA study design5M agoAGMB
The FlyAgomab initiated with a Buy at H.C. Wainwright5M agoAGMB
Company AnnouncementsAgomab Shareholders Approve All 2025 Accounts and Board Reappointments at May 26 AGM5M ago6KAGMB
Company AnnouncementsAgomab Posts 2025 Loss, Fortifies Cash After IPO and Targets Key 2026 Trial Milestones7M ago6KAGMB





